✦ LIBER ✦

A phase II, randomized, multicenter study evaluating the combination of lapatinib and vinorelbine in women with ErbB2 overexpressing metastatic breast cancer

✍ Scribed by Janni, Wolfgang; Sarosiek, Tomasz; Karaszewska, Boguslawa; Pikiel, Joanna; Staroslawska, Elzbieta; Potemski, Piotr; Salat, Christoph; Brain, Etienne; Caglevic, Christian; Briggs, Kathryn; DeSilvio, Michelle; Marini, Luca; Papadimitriou, Christos

Book ID: 121561495
Publisher: Springer US
Year: 2014
Tongue: English
Weight: 399 KB
Volume: 143
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-013-2828-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination docetaxel and trastuzumab tr

Combination docetaxel and trastuzumab treatment for patients with her-2-overexpressing metastatic breast cancer: A multicenter, phase-II study

✍ Nobuaki Sato; Muneaki Sano; Toshio Tabei; Taro Asaga; Jiro Ando; Hirofumi Fujii; 📂 Article 📅 2006 🏛 Springer Japan 🌐 English ⚖ 553 KB

Multicenter phase II study of combinatio

Multicenter phase II study of combination chemotherapy with capecitabine and intravenous vinorelbine in patients with pretreated metastatic breast cancer

✍ Alison J DAVIS; Sue BREW; Val J GEBSKI; Craig R LEWIS; Eugene MOYLAN; Francis X 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

A phase II study of bevacizumab in combi

A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancer

✍ Lin, N. U.; Seah, D. S.; Gelman, R.; Desantis, S.; Mayer, E. L.; Isakoff, S.; Di 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 258 KB

Phase II study of lapatinib in combinati

Phase II study of lapatinib in combination with vinorelbine in patients with HER2 positive recurrent or metastatic breast cancer: A multicentric Turkish Oncology Group (TOG) trial

✍ Saip, P.; Eralp, Y.; Sen, F.; Karaca, H.; Ozkan, M.; Cetin, B.; Benekli, M.; Kuc 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 232 KB

Multicenter phase II study of trastuzuma

Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer

✍ M. Venturini; C. Bighin; S. Monfardini; F. Cappuzzo; N. Olmeo; A. Durando; F. Pu 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 218 KB

5076 POSTER Phase II Study of Vinorelbin

5076 POSTER Phase II Study of Vinorelbine Plus Trastuzumab in HER-2 Overexpressing Metastatic Breast Cancer Pretreated With Anthracyclines and Taxanes

✍ Kwon, H.; Oh, S.Y.; Kim, S.H.; Lee, S.; Lee, J.H.; Kim, H.J. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB